Back to Search Start Over

A Cohort Study of Anticholinergic Medication Burden and Incident Dementia and Stroke in Older Adults.

Authors :
Lockery, Jessica E.
Broder, Jonathan C.
Ryan, Joanne
Stewart, Ashley C.
Woods, Robyn L.
Chong, Trevor T.-J.
Cloud, Geoffrey C.
Murray, Anne
Rigby, Jason D.
Shah, Raj
Storey, Elsdon
Ward, Stephanie A.
Wolfe, Rory
Reid, Christopher M.
Collyer, Taya A.
Ernst, Michael E.
ASPREE Investigator Group, ASPREE Investigator Group listed on www.aspree.org
Source :
JGIM: Journal of General Internal Medicine. Jun2021, Vol. 36 Issue 6, p1629-1637. 9p. 1 Diagram, 4 Charts.
Publication Year :
2021

Abstract

<bold>Background: </bold>Anticholinergic medications may increase risk of dementia and stroke, but prospective studies in healthy older people are lacking.<bold>Objective: </bold>Compare risk of incident dementia and stroke by anticholinergic burden among initially healthy older people.<bold>Design: </bold>Prospective cohort study.<bold>Setting: </bold>Primary care (Australia and USA).<bold>Participants: </bold>19,114 community-dwelling participants recruited for the ASPREE trial, aged 70+ years (65+ if US minorities) without major cardiovascular disease, dementia diagnosis, or Modified Mini-Mental State Examination score below 78/100.<bold>Measurements: </bold>Baseline anticholinergic exposure was calculated using the Anticholinergic Cognitive Burden (ACB) score. Dementia was adjudicated using Diagnostic and Statistical Manual of Mental Disorders volume IV criteria, and stroke using the World Health Organization definition.<bold>Results: </bold>At baseline, 15,000 participants (79%) had an ACB score of zero, 2930 (15%) a score of 1-2, and 1184 (6%) a score of ≥ 3 (indicating higher burden). After a median follow-up of 4.7 years and adjusting for baseline covariates, a baseline ACB score of ≥ 3 was associated with increased risk of ischemic stroke (adjusted HR 1.58, 95% CI 1.06, 2.35), or dementia (adjusted HR 1.36, 95% CI 1.01, 1.82), especially of mixed etiology (adjusted HR 1.53, 95% CI 1.06, 2.21). Results were similar for those exposed to moderate/highly anticholinergic medications.<bold>Limitations: </bold>Residual confounding and reverse causality are possible. Assessment of dose or duration was not possible.<bold>Conclusions: </bold>High anticholinergic burden in initially healthy older people was associated with increased risk of incident dementia and ischemic stroke. A vascular effect may underlie this association. These findings highlight the importance of minimizing anticholinergic exposure in healthy older people. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
08848734
Volume :
36
Issue :
6
Database :
Academic Search Index
Journal :
JGIM: Journal of General Internal Medicine
Publication Type :
Academic Journal
Accession number :
150669196
Full Text :
https://doi.org/10.1007/s11606-020-06550-2